Waters (NYSE:WAT) Releases Q1 2025 Earnings Guidance

Waters (NYSE:WAT) issued an update on its first quarter 2025 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 2.170-2.250 for the period, compared to the consensus earnings per share estimate of 2.430. The company issued revenue guidance of $643.2 million-$662.3 million, compared to the consensus revenue estimate of $673.6 million. Waters also updated its FY 2025 guidance to 12.700-13.000 EPS.

Waters Price Performance

Shares of NYSE WAT traded down $30.60 during trading on Wednesday, reaching $374.69. The company had a trading volume of 506,772 shares, compared to its average volume of 416,838. The stock has a 50-day moving average price of $390.34 and a two-hundred day moving average price of $363.72. The company has a current ratio of 2.02, a quick ratio of 1.38 and a debt-to-equity ratio of 1.14. The stock has a market capitalization of $22.25 billion, a PE ratio of 35.56, a price-to-earnings-growth ratio of 7.37 and a beta of 1.01. Waters has a twelve month low of $279.24 and a twelve month high of $423.56.

Waters (NYSE:WAT) last released its quarterly earnings data on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share for the quarter, beating the consensus estimate of $4.02 by $0.08. Waters had a return on equity of 49.93% and a net margin of 21.43%. As a group, sell-side analysts predict that Waters will post 11.79 earnings per share for the current year.

Analysts Set New Price Targets

A number of brokerages recently weighed in on WAT. Scotiabank assumed coverage on shares of Waters in a research report on Monday, December 23rd. They set a “sector perform” rating and a $430.00 price target for the company. TD Cowen upped their target price on Waters from $363.00 to $410.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. Bank of America raised their target price on Waters from $400.00 to $430.00 and gave the company a “neutral” rating in a report on Friday, December 13th. Wells Fargo & Company boosted their price target on Waters from $380.00 to $415.00 and gave the stock an “overweight” rating in a research report on Monday, November 4th. Finally, Cfra set a $389.00 price objective on shares of Waters in a research report on Thursday, October 17th. Ten research analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, Waters presently has a consensus rating of “Hold” and an average target price of $388.64.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.